Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eperisone BID vs TID in Acute Low Back Pain
NCT01806818Phase 2Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Feb 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eperisone in low back pain (LBP), sponsored by Hanmi Pharmaceutical. Started Feb 2013; status: completed.
02
Drugs
eperisone
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT01806818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806818.